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ABSTRACT
Background and Objectives: Major epicardial fat pads contain cardiac ganglionated plexi (GP) of the autonomic nervous 
system. Autonomic denervation may improve the success rate of atrial fibrillation (AF) ablation. This study was designed to el-
ucidate the acute effects of blocking the right atrium-pulmonary vein (RA-PV) and left atrium-inferior vena cava (LA-IVC) 
fat pads on the electrophysiologic characteristics of the atrium and AF inducibility with a botulinum toxin injection. Materi-
als and Methods: Eight mongrel dogs were studied. The RA-PV and LA-IVC fat pads were exposed through a median th-
oracotomy. Botulinum toxin (BT, 50 U to each fat pad, n=6) or normal saline (NS, n=2) was injected in the entire area of two 
fat pads. The study protocol was applied before injection and repeated at 1, 2, 3, 4, and 5 hours thereafter. The sinus rate, ven-
tricular rate during rapid atrial pacing with a cycle length of 50 ms, and AF inducibility were measured with and without va-
gal stimulation (VS). Bilateral cervical VS was applied (20 Hz, 0.2 ms, 5.6±2.0 V). AF inducibility was evaluated with burst 
pacing with 200 impulses at a 50-ms cycle length. Results: VS effects on the sinus node and AF inducibility were eliminated 
a few hours after injection of BT; these changes were not observed after injection of NS. Conclusion: Short-term autonomic 
denervation of the atria was achieved by blocking the major epicardial GP with BT. (Korean Circ J 2010;40:387-390)
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Introduction
The autonomic innervation of the heart is rich and asym-
metric.
1) The postganglionic parasympathetic neurons are 
primarily located in the fat pads, whereas the postganglionic 
sympathetic nerves originate from the extracardiac sites, the 
stellate ganglia, and the sympathetic trunks, and course along 
the great arteries. Canine hearts have three well-known epi-
cardial fat pads that contain cardiac ganglionated plexi (GP) 
of the autonomic nervous system. The major GPs are the right 
pulmonary vein (RPV) fat pad (the so-called sinus nodal fat 
pad), the inferior vena cava-left atrium (IVC-LA) fat pad [the 
so-called atrioventricular (AV) nodal fat pad], and the super-
ior vena cava (SVC)-aorta fat pad (the so-called third fat pad), 
which are referred to as the “head station.”
2) In the human he-
art, the existence and location of epicardial fat pads also seem 
to be similar with those of the canine heart.
3)4) 
Both vagal and sympathetic stimulation can shorten the at-
rial effective refractory period (ERP), action potential dura-
tion, and re-entrant wavelength. Vagal activation also affects 
the duration of the refractory period and the heterogeneity 
of refractoriness. The initiation and maintenance of atrial fi-
brillation (AF) are highly dependent on these electrophysio-
logic characteristics; therefore, they could be important in the 
pathophysiology of AF.
The effects of denervation on ventricular arrhythmia has 
been evaluated in animal models by several investigators.
5) The 
effects on AF has also been introduced using animal models. 
AF was not inducible after major epicardial fat pad ablation.
2) 
Fat pad ablation was also achievable by a transvenous appro-
ach to suppress AF.
6) In humans, GP ablation combined with 
PV isolation has a reasonable success rate.
7-9) 
Botulinum toxin (BT) is a neurotoxin produced by Clos-
tridium botulinum, which functions as zinc-binding metal-
loendopeptidases. The mechanism of action is blocking of ex-
ocytotic release of acetylcholine stored in synaptic vesicles.
10) 
Therefore, BT blocks cholinergic neurotransmission, which 388   Cardiac Denervation Using Botulinum Toxin
is important in postganglionic neurons. Injection of BT into 
the sinus nodal fat pad blocks bradycardia mediated by para-
sympathetic activation in the dog heart.
11) This study was 
designed to elucidate the acute effects of blocking the right at-
rium-pulmonary vein (RA-PV) and left atrium-inferior vena 
cava (LA-IVC) fat pads on the electrophysiologic character-
istics of the atrium and AF inducibility with BT.
Materials and Methods
Surgical preparation
This study protocol was approved by the Seoul National 
University Hospital Institutional Animal Care and Use Com-
mittee. Eight adult male mongrel dogs weighing 15-20 kg were 
studied. Following standard and approved protocols, all dogs 
were anesthetized with thiopental (20 mg/kg IV), intubated, 
and oxygenated followed by gaseous anesthesia (1-2% iso-
fluorane/O2). All measures were taken to ensure that discom-
fort, distress, pain, and injury were limited to that which was 
unavoidable. Standard surface ECG leads were monitored 
continuously throughout the entire study. Intermittent arte-
rial blood gas measurements were obtained and ventilator 
adjustments were made to correct any metabolic abnormali-
ties. An electrical heating pad was used to maintain body the 
temperature at 36-37℃ . 
Vagal stimulation protocol
Bilateral cervical vagal stimulation (VS) was applied using 
stainless steel electrodes (Model 6491, Unipolar Pediatric Tem-
porary Pacing Lead; Medtronic, Minneapolis, MN, USA) at 
intensities sufficient to double the sinus cycle length. Typical 
parameters for the cervical VS trains were a frequency of 20 
Hz, a pulse width of 0.2 ms, and a current amplitude of 4-10 V 
with a Grass stimulator (S-88; Astro-Med, Warwick, MA, USA). 
Botulinum toxin injection
A median thoracotomy was performed. After exposure of 
the posterior side of the heart, BT (50 U/1 mL in each fat pad 
of six dogs Allergan, Inc., Irvine, CA, USA) or normal saline 
(NS, 1 mL in each fat pad of two dogs) was injected epicar-
dially to the entire visible areas of the two major epicardial fat 
pads (RPV and IVC-LA fat pads). The dose of BT used in this 
study was within the range of the usual clinical dose, there-
fore the systemic effects were insignificant. The locations of 
both fat pads are illustrated in a previous report.
12) The needle 
tip was positioned manually at several points on the epicar-
dial surface of the fat pads under direct visual control to ensure 
optimal injection. 
Electrophysiologic study protocol
The study protocol was applied before BT or NS injection 
and repeated 1, 2, 3, 4, and 5 hours later. Electrocardiograph-
ic and atrial electrograms were amplified and filtered from 
0.05-500 Hz, and were displayed and recorded on a Prucka 
Cardiolab EP System (GE Medical Systems, Fairfield, CT, 
USA). Two epicardial pacing electrodes (Capsure Epi, Med-
tronic, Minneapolis, MN, USA) were placed at the right at-
rial free wall. Atrial pacing was performed with twice the 
current threshold. AV nodal function was evaluated by meas-
uring the ventricular response rate during rapid atrial pac-
ing (RAP) with 50-ms cycle length, mimicking the ventricu-
lar response during AF. The sinus and ventricular rate was cal-
culated using the average RR interval of 20 beats. AF indu-
cibility was evaluated with burst pacing using 200 impulses 
at a 50-ms cycle length, which was performed 4 times in each 
animal during VS. Spontaneous AF that lasted >30 seconds 
after the end of the burst stimulation was defined as sustained. 
The incidence of sustained AF expressed as a percent of the 
total attempts was defined as AF inducibility.
Statistics
All data are presented as the mean±standard deviation. 
The Mann-Whitney U-test was used for data comparison. P 
<0.05 were considered statistically significant.
Results
Effects on the sinus and atrioventricular nodes
Visually-estimated myocardial contractility was grossly 
intact during the study. The sinus nodal function was sup-
pressed during VS. VS reduced the sinus rate (57±14% vs. non-
VS) before fat pad injection. The effect on sinus rate reduc-
tion was decreased gradually to 82±22% five hours after in-
jection of BT (Fig. 1A). However, these changes were not 
remarkable after injection of NS. The denervation effect of BT 
on the sinus node was significant 3 hours after BT injection.
The AV nodal function was also suppressed during VS. The 
ventricular response rate during VS was reduced to 39±22% 
in comparison to non-VS. This effect was decreased gradual-
ly to 66±35% at 5 hours (Fig. 1B). However, the denervation 
effect of BT on the AV node was not significant. Ventricular 
response rate patterns were not different statistically between 
BT and NS.
Effects on atrial fibrillation inducibility
AF inducibility was 58±29% before injection. AF was signifi-
cantly reduced 3 hours after injection, and AF was not induced 
at 4 and 5 hours in the BT group (Fig. 2); however, suppres-
sion of AF inducibility was not observed in NS group. 
Discussion
Major findings
This is the first study to evaluate the effects of GP blocking Seil Oh, et al.   389
using BT on AF inducibility in the dog. The VS effects on the 
sinus node and AF inducibility were significantly eliminated 
a few hours after BT injection. These findings suggest that 
short-term denervation of the atria may be achievable by BT 
in this canine model. 
Long-term effects of GP block utilizing radiofrequency 
ablation on cardiac innervation might be difficult to achieve. 
It has been demonstrated in an animal model.
12) In addition, 
human GP ablation for the management of patients with AF has 
been evaluated by several investigators. The effectiveness and 
outcome of GP ablation as a stand-alone therapy do not seem 
to be as good as conventional PV isolation procedures.
13)14) 
However, short-term GP block would be applicable in some 
clinical field, such as prevention of post-cardiac surgery AF, 
although its mechanism has not been well-established. For 
this purpose, a temporary GP block without permanent de-
struction of GP using BT would be a novel management. To 
consider human application, the safety of the procedure sh-
ould be evaluated and how long the denervation effects per-
sist should be determined.
Different vagal effects on the sinus and atrioventric-
ular nodes
The denervation effect of BT on the AV node was not re-
markable. One has to keep in mind that we injected BT into 
only two major epicardial fat pads. The majority of the right 
vagal fibers innervate the sinus node and they run predomi-
nantly through the RPV fat pad (anterior right GP). In con-
trast, fewer right vagal fibers reach the AV node via IVC-LA 
fat pad (inferior right GP). There are more GPs (e.g., superi-
or left GP and inferior left GP) innervating the left atria and 
the AV node although the IVC-LA fat pad would be the ma-
jor control station of the AV node. Therefore effective dener-
vation of the AV node might be difficult to achieve by block-
ing only two fat pads. Such an explanation needs experimental 
testing by all GPs plus the third fat pad block.
Study limitations
We did not block the third fat pad as well as the left-side 
GPs in the present study, as described previously. However, 
total denervation would not be achievable even with abla-
tion of all these GPs, although the completeness of denerva-
tion would be higher. This is because efferent fibers bypass-
ing the GPs in dogs have been identified.
2) Therefore a 100% 
denervation might be impossible in any case. 
We did not decentralize the cervical vagal trunks, so we 
cannot rule out the effect of afferent nerve activation. We did 
not use sympathetic system blockade, such as beta-blocker 
or sympathetic ganglia destruction. Thus, sympathetic acti-
vation during the procedures might have affected the results 
of the present study. However, we successfully kept all vital 
signs stable in the animals during the experimental procedures. 
Therefore, the variation of the sympathetic tone might be min-
imal.
We did not measure the atrial ERP. Thus, we do not know 
whether a BT injection affected that ERP could be associated 
with AF vulnerability. 
Fig. 1. Vagal stimulation effect on the sinus and atrioventricular nodes. A: sinus rate during VS (%) vs. non-VS. B: ventricular response rate 
during VS (%) vs. non-VS. The abscissa indicates time after injection (BT or NS). Error bars indicate one standard deviation. *p<0.05 for BT 
vs. NS. VS: vagal stimulation, non-VS: baseline state without VS, BT: botulinum toxin group, NS: normal saline group. 
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Fig. 2. AF inducibility. The abscissa indicates time after injection 
(BT or NS). Error bars indicate one standard deviation. Error bars 
indicate one standard error. *p<0.05 for BT vs. NS. AF: atrial fibril-
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Conclusion
Short-term autonomic denervation was achieved by block-
ing the major epicardial GP with BT.
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